Top Markets
Coin of the day
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
Kedudukan dalam Saham #25548
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
Harga Saham
$20.01
Disegerakkan terakhir: 2025-02-21
Modal Pasaran
$48.36M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Singular Genomics Systems, Inc. (OMIC)

Kategori

Pendapatan untuk Singular Genomics Systems, Inc. (OMIC)
Pendapatan pada Sep 2024 TTM: $-86.32M
Menurut laporan kewangan terkini Singular Genomics Systems, Inc., pendapatan semasa syarikat ialah $-86.32M. Pada tahun 2022, syarikat memperoleh pendapatan sebanyak $-90.88M, peningkatan berbanding pendapatan pada tahun 2021 yang berjumlah $-98.77M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Singular Genomics Systems, Inc. dari 2019 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $-86.32M -8.96%
2023 $-94.82M 4.34%
2022 $-90.88M -7.99%
2021 $-98.77M 253.45%
2020 $-27.95M 126.75%
2019 $-12.32M 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$3.81B -4,508.84%
US
$4.11B -4,859.90%
FR
- -
JP
$1.59B -1,941.94%
US
- -
CH